Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 16 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

Phase 2
10(71.4%)
Phase 3
2(14.3%)
N/A
2(14.3%)
14Total
Phase 2(10)
Phase 3(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials
NCT06072781Phase 3Recruiting

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

Role: collaborator

NCT07295132Phase 2Not Yet Recruiting

RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse)

Role: collaborator

NCT05421650Not ApplicableRecruiting

Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr

Role: collaborator

NCT01658930Not ApplicableCompleted

Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer

Role: collaborator

NCT03699449Phase 2Unknown

An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION)

Role: collaborator

NCT03899610Phase 2Unknown

A Phase II Study of Neoadjuvant Chemotherapy Plus Durvalumab (MEDI4736) and Tremelimumab in Advanced-stage Ovarian Cancer (TRU-D)

Role: collaborator

NCT04063527Phase 3Recruiting

Phase III Trial of Stage I Ovarian Cancer After Surgery

Role: collaborator

NCT03567655Phase 2Unknown

Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer

Role: collaborator

NCT01527396Completed

Prospective, Observational Study of Low-risk Criteria for Node Metastasis in Endometrial Cancer

Role: collaborator

NCT02412072Unknown

Comparison of Dilatation & Curettage and Endometrial Aspiration Biopsy Accuracy in Patients Treated With Progestin for Endometrial Hyperplasia: A Korean Gynecologic Oncology Group Study

Role: lead

NCT01234818Phase 2Unknown

Management of Endometrial Hyperplasia With a LNG-IUS: Multicenter Study: KGOG2006

Role: lead

NCT01594879Phase 2Unknown

Treatment With Medroxyprogesterone Acetate Plus LNG-IUS in Young Women With Early Stage Endometrial Cancer

Role: lead

NCT01570582Phase 2Unknown

A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Role: lead

NCT01487226Phase 2Unknown

Adjuvant Chemotherapy in Patients With Lymph Node Metastasis After Radical Surgery in Cervical Cancer

Role: lead

NCT00340184Phase 2Completed

A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients

Role: lead

NCT00373620Phase 2Unknown

A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients

Role: lead

All 16 trials loaded